Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
German Clinical Trials Register |
Last refreshed on:
|
8 April 2024 |
Main ID: |
DRKS00009868 |
Date of registration:
|
13/01/2016 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Procedural and Clinical Outcome after Low Speed Coronary Rotational Atherectomy
|
Scientific title:
|
Procedural and Clinical Outcome after Low Speed Coronary Rotational Atherectomy
- LS_CoRA |
Date of first enrolment:
|
20/01/2016 |
Target sample size:
|
180 |
Recruitment status: |
Pending |
URL:
|
http://drks.de/search/en/trial/DRKS00009868 |
Study type:
|
observational |
Study design:
|
Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment
|
Phase:
|
|
|
Countries of recruitment
|
Austria
| | | | | | | |
Contacts
|
Name:
|
Oliver
Friedrich |
Address:
|
Heinrich-Collin-Str. 30
1140
Wien
Austria |
Telephone:
|
+ 43 1 910 21-85211 |
Email:
|
o.friedrich@karl-landsteiner.at |
Affiliation:
|
Karl Landsteiner Institut für Wissenschaftliche Forschung in der Klinischen Kardiologie |
|
Name:
|
Oliver
Friedrich |
Address:
|
Heinrich-Collin-Str. 30
1140
Wien
Austria |
Telephone:
|
+ 43 1 910 21-85211 |
Email:
|
o.friedrich@karl-landsteiner.at |
Affiliation:
|
Karl Landsteiner Institut für Wissenschaftliche Forschung in der Klinischen Kardiologie |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Treatment with Slow-Speed Rotablatory Atherectomy
Exclusion criteria: no adequate German language skills to answer patient-reported questionnaires
Age minimum:
18 Years
Age maximum:
None
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
I20-I25
|
Ischaemic heart diseases
|
I20-I25
|
Intervention(s)
|
Group 1: Procedural and clinical outcome in CAD patients after slow-speed rotablatory atherectomy
|
Primary Outcome(s)
|
Procedural outcome Angiographic success (Quantitative Coronary Angiography, TIMI-flow and myocardial blush prior and after intervention), procedural complications (dissection, perforation, slow flow/no flow, early stent thrombosis, myocardial infarction, cardiac and noncardiac death)
|
Secondary Outcome(s)
|
Clinical outcome up to 48 months: Adverse Events (repeated target and non-target vessel revascularisation – Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting), myocardial infarction; cardiac/non-cardiac death) Patient reported questionnaires for Health Related Quality of Life and Illness Perception (HeartQoL and BIPQ) at baseline, 6 months, 12 months and at the end of the follow-up period (24-48 months after index event).
|
Source(s) of Monetary Support
|
Boston Scientific Group - ISR program
|
Ethics review
|
Status: Approved
Approval date: 21/12/2015
Contact:
Ethikkommission der Stadt Wien Magistratsabteilung 15 - Gesundheitsdienst [EK der Stadt Wien
Magistratsabteilung 15 - Gesundheitsdienst]
|
|